Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fresenius SE & Co KGaA (OTCQX International Premier:FSNUY)

19.82
Delayed Data
As of 3:59pm ET
 +0.0776 / +0.39%
Today’s Change
16.90
Today|||52-Week Range
20.43
+1.72%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$43.7B

Company Description

Fresenius SE & Co. KGaA is a global healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment is comprised of dialysis products, and healthcare services. The Fresenius Kabi segment provides intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios is the hospital operations. The Fresenius Vamed is consist of projects, and services for hospitals and other healthcare facilities. The Corporate and Other segment is the holding activities of the company and the information provider Fresenius Netcare. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Contact Information

Fresenius SE & Co. KGaA
Else-Kröner-Strasse 1
Bad Homburg Hessen 61352
P:(496) 172-6080
Investor Relations:
4961726082485

Employees

Shareholders

Other institutional0.08%
Mutual fund holders0.00%
Individual stakeholders--

Top Executives

Stephan SturmPresident & Chief Executive Officer
Jürgen GötzChief Legal, Compliance & Human Resources Officer
Rice PowellMember-Management Board
Francesco de MeoMember-Management Board
Ernst WastlerMember-Management Board